CROSSJECT’s ZENEO® needle-free auto-injector consistently matches depth of traditional intramuscular injections and exceeds the standards needle length of currently utilized auto-injectors Injection ...
For certain people with severe allergies, sometimes combined with asthma, a higher risk for anaphylaxis -- a rare allergic reaction that's a life-threatening medical emergency -- is a concern. As a ...
BASKING RIDGE, N.J., Oct. 26-- Dey Pharma, L.P., a subsidiary of Mylan Inc. (Nasdaq: MYL), today launched a newly designed, patient-friendly EpiPen® Auto-Injector 0.3/0.15 mg. This next-generation ...
EPIPEN (epinephrine [1:1000]) 0.3mg auto-injection device by DEY Pharma DEY Pharma has launched re-designed EpiPen and EpiPen Jr. Auto-Injectors (epinephrine [1:1000]) that feature needle-protection, ...
EWING, N.J.--(BUSINESS WIRE)--Antares Pharma, Inc. (NYSE Amex:AIS), a leader in self-injection drug delivery technology, today announced the latest advancement in its proprietary line of VIBEX™ ...
(HealthDay News) — Given the increasing epidemic of obesity, epinephrine autoinjectors (EAIs) for anaphylaxis require longer needles to ensure intramuscular injection, according to a study published ...
The auto injector market represents a rapidly expanding segment within the global pharmaceutical delivery systems industry, driven by the increasing prevalence of chronic diseases and the growing ...
CROSSJECT's ZENEO® needle-free auto-injector consistently matches depth of traditional intramuscular injections and exceeds the standards needle length of currently utilized auto-injectors Injection ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results